Session Details
Name
[L&L] Mandibular Advancement Devices for OSA: Evidence-Based Treatment & the DME Partnership Model
Track
Respiratory
Date & Time
Tuesday, June 9, 2026, 12:15 PM - 1:00 PM
Location Name
Room 3 & 4
Presentation
Speakers
Learning Objectives
Name
[L&L] Mandibular Advancement Devices for OSA: Evidence-Based Treatment & the DME Partnership Model
Description
Step into the evolving world of obstructive sleep apnea treatment, where evidence-based insights are challenging the traditional CPAP-only mindset. This engaging session explores how mandibular advancement devices are reshaping patient care through improved compliance, strong clinical outcomes, and a more personalized approach grounded in clinical research. You’ll also get a glimpse into a modern partnership model that expands access while aligning care delivery with real-world results. If you’re ready to rethink what effective, evidence-driven treatment truly looks like, this session is one you won’t want to miss.
Proposed Learning Objective (1)
Differentiate between FDA-cleared custom MADs and OTC boil-and-bite snoring appliances
Proposed Learning Objective (2)
Identify indications and contraindications for MAD therapy
Proposed Learning Objective (3)
Explain Mean Disease Alleviation (MDA) and why MAD compliance produces comparable outcomes to CPAP
Proposed Learning Objective (4)
Describe a MAD titration protocol: weekly symptom surveys, adjustments, and efficacy testing
CEU and CEC
When applicable, the CEU or CEC credits for each accrediting body are displayed below.
ABC CEU
0.75
BOC 1 CEU
0
BOC 2 CEU
1.0
AARC CEU
0.75
CEAC CEC
0.75
IACET CEU
0.1
SHRM CEU
0
Contact Hours
0.75